Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
World Journal of Surgical Oncology
|
February 22, 2017
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC
Melissa L Abel, George Kokosis, Dan G Blazer
Journal of the American Heart Association
|
December 16, 2021
Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
Rachel E Ohman, Eric H Yang, Melissa L Abel
Current Oncology Reports
|
February 22, 2025
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?
Lauren O'Loughlin, Melissa L Abel, Ravi A Madan, et al.
The Journal of Biological Chemistry
|
January 10, 2014
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization
Julia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
The Oncologist
|
December 27, 2025
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Jaydira Del Rivero, Renee N Donahue, Jennifer L Marte, et al.
Blood
|
October 2, 2013
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
Angela G Fleischman, Julia E Maxson, Samuel B Luty, et al.
Development (Cambridge, England)
|
February 25, 2018
Microbiota promote secretory cell determination in the intestinal epithelium by modulating host Notch signaling
Joshua V Troll, M Kristina Hamilton, Melissa L Abel, et al.
Science Signaling
|
July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia
Chelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Molecular & Cellular Proteomics : MCP
|
June 5, 2014
Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics
Min-Sik Kim, Yi Zhong, Shinichi Yachida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2015
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I
Julia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
World Journal of Surgical Oncology
|
February 22, 2017
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC
Melissa L Abel, George Kokosis, Dan G Blazer
Journal of the American Heart Association
|
December 16, 2021
Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
Rachel E Ohman, Eric H Yang, Melissa L Abel
Current Oncology Reports
|
February 22, 2025
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?
Lauren O'Loughlin, Melissa L Abel, Ravi A Madan, et al.
The Journal of Biological Chemistry
|
January 10, 2014
Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization
Julia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
The Oncologist
|
December 27, 2025
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Jaydira Del Rivero, Renee N Donahue, Jennifer L Marte, et al.
Blood
|
October 2, 2013
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition
Angela G Fleischman, Julia E Maxson, Samuel B Luty, et al.
Development (Cambridge, England)
|
February 25, 2018
Microbiota promote secretory cell determination in the intestinal epithelium by modulating host Notch signaling
Joshua V Troll, M Kristina Hamilton, Melissa L Abel, et al.
Science Signaling
|
July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia
Chelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Molecular & Cellular Proteomics : MCP
|
June 5, 2014
Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics
Min-Sik Kim, Yi Zhong, Shinichi Yachida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2015
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I
Julia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Page
of 2